243
Views
31
CrossRef citations to date
0
Altmetric
Original Research

A network pharmacology approach to explore active compounds and pharmacological mechanisms of epimedium for treatment of premature ovarian insufficiency

, , , &
Pages 2997-3007 | Published online: 22 Aug 2019

References

  • Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68(4):499–509. doi:10.1111/j.1365-2265.2007.03073.x17970776
  • Nippita TA, Baber RJ. Premature ovarian failure: a review. Climacteric. 2007;10(1):11–22. doi:10.1080/13697130601135672
  • Goswami D, Conway GS. Premature ovarian failure. Horm Res. 2007;68(4):196–202. doi:10.1159/00010253717495481
  • Del Mastro L, Ceppi M, Poggio F, et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev. 2014;40(5):675–683. doi:10.1016/j.ctrv.2013.12.00124360817
  • Chen H, Xiao L, Li J, et al. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. 2019;3:CD008018. doi:10.1002/14651858.CD008018.pub330827035
  • Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol off J Am Soc Clin Oncol. 2008;26(5):753–758. doi:10.1200/JCO.2007.14.1655
  • Kovanci E, Schutt AK. Premature ovarian failure: clinical presentation and treatment. Obstet Gynecol Clin North Am. 2015;42(1):153–161. doi:10.1016/j.ogc.2014.10.00425681846
  • Pinelli S, Artini PG, Basile S, et al. Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis. J Assist Reprod Genet. 2018;35(3):475–482. doi:10.1007/s10815-017-1096-y29204869
  • Chinese Flora Compilation Committee of Chinese Academy of Sciences.Flora of China (volume 27). Beijing, China: Science Press; 1979:296–299.
  • Chen XJ, Tang ZH, Li XW, et al. Chemical constituents, quality control, and bioactivity of epimedii folium (Yinyanghuo). Am J Chin Med. 2015;43(5):783–834. doi:10.1142/S0192415X1550049426243581
  • Indran IR, Liang RL, Min TE, et al. Preclinical studies and clinical evaluation of compounds from the genus epimedium for osteoporosis and bone health. Pharmacol Ther. 2016;162:188–205. doi:10.1016/j.pharmthera.2016.01.01526820757
  • Chao SL, Huang LW, Yen HR. Pregnancy in premature ovarian failure after therapy using Chinese herbal medicine. Chang Gung Med J. 2003;26(6):449–452.12956293
  • Sheng C, Xu P, Zhou K, et al. Icariin attenuates synaptic and cognitive deficits in an A-induced rat model of alzheimer’s disease. Biomed Res Int. 2017;2017:7464872. doi:10.1155/2017/746487229057264
  • Wang GQ, Li DD, Huang C, et al. Icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro. Front Mol Neurosci. 2018;9(10):441. doi:10.3389/fnmol.2017.00441
  • Wei Z, Deng X, Hong M, et al. Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects. Int J Clin Exp Med. 2015;8(11):20188–20197.26884931
  • Park HJ, Koo YK, Park MJ, et al. Restoration of spermatogenesis using a new combined herbal formula of epimedium koreanum nakai and angelica gigas nakai in an luteinizing hormone-releasing hormone agonist-induced rat model of male infertility. World J Mens Health. 2017;35(3):170–177. doi:10.5534/wjmh.1703129076302
  • Nie X, Sheng W, Hou D, et al. Effect of Hyperin and Icariin on steroid hormone secretion in rat ovarian granulosa cells. Clin Chim Acta. 2019;495:646–651. doi: 10.1016/j.cca.2018.05.004
  • Liu AL, Du GH. [Network pharmacology: new guidelines for drug discovery]. Yao Xue Xue Bao. 2010;45(12):1472–1477.21351485
  • Zhang Y, Guo X, Wang D, et al. A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma. Sci Rep. 2014;24(4):4154. doi:10.1038/srep04154
  • Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682–690. doi:10.1038/nchembio.11818936753
  • Hopkins AL. Network pharmacology. Nat Biotechnol. 2007;25(10):1110–1111. doi:10.1038/nbt1007-111017921993
  • Gao L, Wang XD, Niu YY, et al. Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology. Sci Rep. 2016;4(6):24944. doi:10.1038/srep24944
  • Kim S, Thiessen PA, Bolton EE, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44(D1):D1202–D1213. doi:10.1093/nar/gkv95126400175
  • Wang X, Shen Y, Wang S, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45(W1):W356–W360. doi:10.1093/nar/gkx37428472422
  • Brown GR, Hem V, Katz KS, et al. Gene: a gene-centered information resource at NCBI. Nucleic Acids Res. 2015;43(Database issue):D36–D42. doi:10.1093/nar/gku105525355515
  • Amberger J, Bocchini CA, Scott AF, et al. McKusick’s Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res. 2009;37(Database issue):D793–D796. doi:10.1093/nar/gkn66518842627
  • Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–D368. doi:10.1093/nar/gkw93727924014
  • Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.123930314597658
  • Huang Da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.21119131956
  • Nam SY, Jeong HJ, Kim HM. Kaempferol impedes IL-32-induced monocyte-macrophage differentiation. Chem Biol Interact. 2017;274:107–115. doi:10.1016/j.cbi.2017.07.01028711657
  • Xu F, Ding Y, Guo Y, et al. Anti-osteoporosis effect of Epimedium via an estrogen-like mechanism based on a system-level approach. J Ethnopharmacol. 2016;177:148–160. doi:10.1016/j.jep.2015.11.00726593211
  • Shui YM, Lv GY, Shan LT, et al. Epimedin C promotes vascularization during BMP2-induced osteogenesis and tumor-associated angiogenesis. Am J Chin Med. 2017;45(5):1093–1111. doi:10.1142/S0192415X1750059828659032
  • Tsai CH, Tzeng SF, Hsieh SC, et al. A standardized extract overcomes the feedback activation of HER2/3 Signaling upon androgen-ablation in prostate cancer. Front Pharmacol. 2017;8:721. doi:10.3389/fphar.2017.0072129066975
  • Shiina H, Matsumoto T, Sato T, et al. Premature ovarian failure in androgen receptor-deficient mice. Proc Natl Acad Sci USA. 2006;103(1):224–229. doi:10.1073/pnas.050673610216373508
  • Li J, Dalgleish R, Vujovic S, et al. Microsatellite variation of ESR1, ESR2, and AR in Serbian women with primary ovarian insufficiency. Climacteric. 2018;21(5):472–477. doi:10.1080/13697137.2018.147696730156935
  • Liu L, Tan R, Cui Y, et al. Estrogen receptor α gene (ESR1) polymorphisms associated with idiopathic premature ovarian failure in Chinese women. Gynecol Endocrinol. 2013;29(2):182–185. doi:10.3109/09513590.2012.73111323116284
  • Ding C, Li H, Wang Y, et al. Different therapeutic effects of cells derived from human amniotic membrane on premature ovarian aging depend on distinct cellular biological characteristics. Stem Cell Res Ther. 2017;8(1):173. doi:10.1186/s13287-017-0601-728750654
  • Frampton JE. Triptorelin: a review of its use as an adjuvant anticancer therapy in early breast cancer. Drugs. 2017;77(18):2037–2048. doi:10.1007/s40265-017-0849-329177573
  • Yorgun H, Tokgözoğlu L, Canpolat U, et al. The cardiovascular effects of premature ovarian failure. Int J Cardiol. 2013;168(1):506–510. doi:10.1016/j.ijcard.2012.09.19723073277
  • Medenica S, Nedeljkovic O, Radojevic N, et al. Thyroid dysfunction and thyroid autoimmunity in euthyroid women in achieving fertility. Eur Rev Med Pharmacol Sci. 2015;19(6):977–987.25855922
  • Ayesha, Jha V, Goswami D. Premature ovarian failure: an association with autoimmune diseases. J Clin Diagn Res. 2016;10(10):QC10–QC12. doi:10.7860/JCDR/2016/22027.8671
  • Bachelot A, Meduri G, Massin N, et al. Ovarian steroidogenesis and serum androgen levels in patients with premature ovarian failure. J Clin Endocrinol Metab. 2005;90(4):2391–2396. doi:10.1210/jc.2004-173415671097
  • Jeon YJ, Choi Y, Shim SH, et al. Vascular endothelial growth factor gene polymorphisms in Korean patients with premature ovarian failure. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):138–142. doi:10.1016/j.ejogrb.2011.07.00721831507
  • Zhang H, Mehmood K, Li K, et al. Icariin ameliorate thiram-induced tibial dyschondroplasia via regulation of WNT4 and VEGF expression in broiler chickens. Front Pharmacol. 2018;9:123. doi:10.3389/fphar.2018.0012329527166
  • Wang X, Zheng N, Dong J, et al. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells. J Steroid Biochem Mol Biol. 2017;171:318–327. doi:10.1016/j.jsbmb.2017.05.00928529129
  • Yan Z, Dai Y, Fu H, et al. Curcumin exerts a protective effect against premature ovarian failure in mice. J Mol Endocrinol. 2018;60(3):261–271. doi:10.1530/JME-17-021429437881
  • Le Borgne M, Chartier N, Buchet-Poyau K, et al. The RNA-binding protein Mex3b regulates the spatial organization of the Rap1 pathway. Development. 2014;141(10):2096–2107. doi:10.1242/dev.10851424803656